Investor Presentation July 2026 The information contained in this presentation has been prepared by Xenitra Limited ACN 150 110 017 (Company).? This presentation contains summary information about the current activities of the Company and its subsidiaries as at the date of this presentation....
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Xenitra
- Quarterly Activities/Appendix 4C Cash Flow Report
- Investor Webinar
- $12M offtake agreement with leading OTC-pharmaceutical
- $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks
- XEN Appointed as Exclusive Biomiq Skincare China Distributor
Later from Xenitra
- $5m Offtake Agreement Expands OTC-Medicine Business
- Trading Halt
- Proposed issue of securities - XEN
- Xenitra Raises $1.5m to Accelerate High-Margin Sales Growth
- Appendix 4E and Annual Report
Follow Xenitra into a list and get an email when it puts out news.
Follow Xenitra